16.07.2025 10:14:37: Sorry, an unexpected error occurred. Please reload the page and try again..

WO2025128057 - A SACHET FORMULATION COMPRISING BRIVARACETAM

National phase entry is expected:
Publication Number WO/2025/128057
Publication Date 19.06.2025
International Application No. PCT/TR2024/051508
International Filing Date 09.12.2024
Title [English] A SACHET FORMULATION COMPRISING BRIVARACETAM [French] FORMULATION EN SACHET COMPRENANT DU BRIVARACÉTAM
Applicants ** SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI Esentepe Mahallesi Bahar Sokak Ozdilek River Plaza Vyndham Grand No 13 Ic Kapı No 10 Sisli/Istanbul, TR
Inventors ** SUNEL, Fatih Esentepe Mahallesi Bahar Sokak Ozdilek River Plaza Vyndham Grand No 13 Ic Kapı No 10 Sisli/Istanbul, TR ATAK, Fadime Bilgehan Esentepe Mahallesi Bahar Sokak Ozdilek River Plaza Vyndham Grand No 13 Ic Kapı No 10 Sisli/Istanbul, TR ATAMAN, Seval Esentepe Mahallesi Bahar Sokak Ozdilek River Plaza Vyndham Grand No 13 Ic Kapı No 10 Sisli/Istanbul, TR YAZICI, Ozlem Esentepe Mahallesi Bahar Sokak Ozdilek River Plaza Vyndham Grand No 13 Ic Kapı No 10 Sisli/Istanbul, TR
Priority Data 2023/017170  13.12.2023  TR
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 1033
EPO Filing, Examination 4870
Japan Filing 554
South Korea Filing 578
USA Filing, Examination 2635
MasterCard Visa
Total: 9670
Abstract [English] The present invention relates to a sachet formulation comprising brivaracetam or a pharmaceutically acceptable salt thereof, and at least one sweetener, wherein the amount of brivaracetam is between 1.0% and 15.0% by weight in the total formulation. The present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient process of preparing the sachet formulation. [French] La présente invention concerne une formulation en sachet comprenant du brivaracétam ou un sel pharmaceutiquement acceptable de celui-ci, et au moins un édulcorant, la quantité de brivaracétam étant comprise entre 1,0 % et 15,0 % en poids dans la formulation totale. La présente invention concerne également un procédé simple, rapide, économique, économe en temps et industriellement pratique pour la préparation de la formulation en sachet.